Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!

Organigram Holdings Inc. (OTCQX: OGRMF) announced on September 13th the company has closed its $10 million investment into Hyasynth Biologicals Inc. (Hyasynth). Hyasynth is a cannabis company focused on biological technology and is currently a leader in cannabinoid biotechnology.

This $10 million investment from Organigram is intended to be used toward Hyasynth’s process of converting yeast strains that are genetically modified into phytocannabinoids and compounds that share a close molecular structure to phytocannabinoids.

 

{{cta(‘b491434f-c6aa-4547-b3d4-6a7293c8ad67’)}}